The cost of Januvia (sitagliptin) varies based on the dosage, pharmacy, and whether a healthcare professional prescribes the brand name or the generic. You should speak with your healthcare ...

Zydus Lifesciences Limited reports 30% profit increase, driven by US formulations business, with strong financial position ...

MRK provided 2025 adjusted EPS guidance of $8.88 to $9.03, while the giant drugmaker expects sales of $64.1 billion to $65.6 ...

The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

Sitagliptin (Januvia™) is a new oral agent ... and their interaction with DPP-4-related proteases. Potential side effects resulting from the alteration of action of these messengers include ...

Merck & Co. Inc. shares plunged more than 10% on Tuesday as a weak 2025 outlook overshadowed its upbeat fourth-quarter ...

Most experience exists for sitagliptin (Merck) and vildagliptin (Novartis), which both have a long duration of action, allowing once-daily administration. In drug-naïve subjects with type 2 ...

These three NDAs of Sitagliptin (base ... is a strong validation of Zydus’ strategic investments in the new drug applications portfolio. It “will set the way for further strengthening our ...